This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe

€600 savings expire in:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Europe's premier partnering event
November 4–6, 2024 | Stockholm, SwedenNovember 12–13, 2024 | Digital Partnering

John Boghossian
CEO at Kadence Bio
Presenter

Profile

Kadence Bio is a clinical stage therapeutics company whose mission is to develop innovative therapeutics to address critical unmet needs in sexual and mental health. We are developing a first-in-class treatment for premature ejaculation to bridge the 'intimacy gap' (~3x difference in average time to orgasm between men and women). There is currently no treatment approved by the FDA to treat the condition, which affects up to 20% of men and their partners. Our Board includes the global CMO of GSK.

Agenda Sessions

  • “Take a Chance on Me” Startup spotlight pitch competition

    15:00